Longitudinal studies in Sudan show ethnic differences in incidence and clinical phenotypes associated with Leishmania donovani. Immunologically, bias in type 1 vs type 2 cytokine responses is important. To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL). Multipoint nonparametric analysis (Allegro) linked IL4/IL9 to VL per se (P ¼ 0.002). Transmission disequilibrium testing with robust variance estimates confirmed association in the presence of linkage between VL per se and IL4 (P ¼ 0.008) but not IL9. Stepwise logistic regression analysis showed both IL4RP2 and IL4RP1 markers contributed significantly to the association, suggesting a common disease-associated haplotype. In contrast, IFNGR1 was linked (P ¼ 0.031) and associated (P ¼ 0.007) to PKDL but not VL or VL per se. Hence, polymorphism in a type 2 cytokine gene influences underlying susceptibility to VL, whereas IFNGR1 is specifically related to susceptibility to PKDL.
Introduction
Longitudinal studies in Sudan show marked differences in incidence and clinical phenotypes, for example, clinical vs subclinical visceral leishmaniasis (VL), incidence of post Kala-azar dermal leishmaniasis (PKDL), associated with Leishmania donovani sensu strictu in different ethnic groups with shared environments. 1 Immunologically, balance between interferon-g (IFNg) secreting type 1 vs interleukin-4 (IL4) secreting type 2 T cells is important. 2 More recent studies also suggest a role for regulatory T cells that secrete both IFNg and IL10, 3 with IL10 playing an important role in the development of PKDL. 4 Nonexposed individuals also show differences in patterns of IFNg and/or IL4 production upon stimulation with L. donovani and L. major antigens, 5 suggesting an inherent bias in response that could influence clinical outcome upon exposure to infection. In this context, genes that regulate, or control response to, type 1 and type 2 cytokines are good candidate susceptibility loci. Here, we present data showing that polymorphism at loci within the type 2 cytokine gene cluster on chromosome 5q23.3-q31 may influence underlying susceptibility to VL in Sudan, while polymorphism at the gene IFNGR1 on chromosome 6q23-q24 encoding the type 1 receptor for IFNg may be specifically related to susceptibility to PKDL.
Results
Linkage and allelic association for VL per se with IL4/IL9 Results of multipoint nonparametric analysis using the S pairs scoring function to look for linkage between IL4/IL9 and susceptibility to leishmaniasis are presented in Table 1 . The results provide evidence for linkage between all three markers and a putative disease-susceptibility locus controlling susceptibility to VL with PKDL (IL4RP2: P ¼ 0.008; IL4RP1: P ¼ 0.031; IL9: P ¼ 0.009) and VL per se (IL4RP2: P ¼ 0.002; IL4RP1: P ¼ 0.013; IL9: P ¼ 0.034). These data provide suggestive evidence for a gene(s) at 5q23.3-q33 controlling underlying susceptibility to VL in this Sudanese population.
To narrow down the region of interest that might carry the susceptibility allele within this type 2 cytokine gene cluster, allelic association was determined using the transmission disequilibrium test (TDT). Table 2a shows the global w 2 statistics for TDT with correction for multiple affected sibs in a pedigree. The single markers IL4RP2 and IL4RP1 show significant allelic association with VL alone, PKDL and VL per se. IL4RP2 remains significant for allelic association in the presence of linkage (ie robust test), suggesting that this marker lies close to the functional polymorphism. Using the 'casepseudo-control' data set generated from the families and conditional logistic regression analysis (Table 2b) significant allelic associations with VL per se in the presence of linkage (robust tests) were observed for allele 2 at IL4RP2 (P ¼ 0.0034) and allele 4 at IL4RP1 (P ¼ 0.0007) under a multiplicative model (ie two copies of an allele contribute twice as much as one copy). No dominance effects were observed. For IL4RP2, the odds ratio of disease associated with allele 2 relative to allele 1 was 1.68 (P ¼ 0.003; 95% CI 1.19-2.39). The genotype relative risk for heterozygous 1/2 relative to 1/1 was 2.57 (P ¼ 0.008; 95% CI 1.27-5.18) and for homozygous 2/2 relative to 1/1 was 3.59 (P ¼ 0.003; 95% CI 1.56-8.27). For IL4RP1, the odds ratio of disease associated with allele 4 relative to all other alleles was 2.5 (P ¼ 0.001; 95% CI 1.47-4.24). The genotype relative risk for heterozygous other/4 relative to other/other was not significant, but for homozygous 4/4 relative to other/other was 5.72 (P ¼ 0.001; 95% CI 2.11-15.46). No significant allelic or genotype associations were observed for IL9 using robust variance estimates. Results of the likelihood ratio tests of main effects in a stepwise logistic regression procedure 6 showed that both IL4RP1 allele 4 and IL4RP2 allele 2 contribute significantly to the association, suggesting a common disease-associated functional variant in linkage disequilibrium (LD) with a 2-4 haplotype for IL4RP2-IL4RP1. Overall, the results are consistent with a gene in the close vicinity of the IL4 locus controlling underlying susceptibility to VL.
Linkage and allelic association for PKDL with IFNGR1
Results of single-point nonparametric analysis using the S pairs scoring function to look for linkage between IFNGR1 and susceptibility to leishmaniasis are shown in Table 3 . Weak evidence for linkage was observed for PKDL (P ¼ 0.031), but not for VL per se. Similarly, evidence for allelic association between IFNGR1 and susceptibility to disease was found only for the PKDL Likelihood ratio tests and robust Wald w 2 tests (rows 3-6) of main effects in a stepwise logistic regression procedure were used to determine the relative contributions of disease alleles at IL4RP2 (a2 = allele 2) and IL4RP1 (a4=allele 4) to the observed associations. 1 df tests report allelic contributions; 2 df tests report genotype contributions. All test statistics are shown with/without robust variance estimates to control for nonindependence of marker genotypes in pedigrees. 
Discussion
In this study, we have shown suggestive evidence for linkage and significant allelic association between markers within the genes encoding type 2 cytokines IL4 and IL9 and underlying susceptibility to VL in Sudan. In man, immunological studies suggest that the balance in type 1 vs type 2 cytokine responses is important in L. donovani infection. 2, 7, 8 In relation to clinical VL, IL4 was detected in all Brazilian patient sera 14 and its level increased 13-fold in Indian Kala-azar patients when compared with healthy controls. 15 The role of IL9 in human leishmaniasis is not well documented. During L. major infection in the mouse, no functionally active IL9 is detected in sera of either susceptible BALB/c or resistant C57BL/6 mice, but IL9 mRNA is expressed at higher levels in BALB/c lymph nodes and spleens and IL-9 protein produced at higher level after restimulation of lymphocytes in vitro. 9 In mice, the region on murine chromosome 11 that has conserved synteny with human chromosome 5q23.3-q33 has been specifically shown to be involved in controlling later phases of cutaneous lesion development and visceralisation of L. major in susceptible BALB/c mice. 10 Extensive visceralisation and death following L. major infection in susceptible BALB/c mice make it a better model of clinical visceral leishmaniasis than L. donovani infection in the mouse. Interestingly, while the human IL9 gene maps to 5q31-q32, the mouse gene lies on chromosome 13 outside the region of conserved synteny between human 5q and mouse 11.
11 Hence, if the same gene is responsible for susceptibility to leishmaniasis in mouse and man, IL9 ought not to be the candidate susceptibility gene in the present study. In fact, allelic association data suggest that the IL4 locus itself may be the susceptibility gene in the Sudanese population. However, other candidate genes lie within this region, including genes encoding IL5 and IRF1 B130-190 kb proximal to IL4 and IL13 B360 kb distal to IL4. Studies in mice using single and double knockouts for IL4 and IL13, and transgenic reintroduction of IL13, indicate an independent role for IL13 in susceptibility to L. major infection. 12 Further studies are in progress using a large number of single nucleotide polymorphisms to fine map the disease causing gene/ mutations across this region of 5q23.3 in this Sudanese population.
The corollary to genes regulating type 2 cytokines as candidate susceptibility genes in leishmaniasis are genes causing a defect in the type 1 cytokine pathway. An interesting candidate for interference with type 1 effector activity is polymorphism in the IFNGR1 gene encoding the type 1 IFNg receptor. Studies in man have identified mutations in the gene IFNGR1 in Mendelian inheritance of susceptibility to disseminated atypical mycobacterial infection. 13 Results presented here suggest that polymorphism at IFNGR1 is associated with susceptibility to PKDL but not to underlying VL. Again, further work is required to verify this result and to identify the diseaseassociated mutation/polymorphism in this population. Recent studies suggest that regulatory T cells expressing IFNg and IL10 are expanded in individuals from Sudan with a history of drug-cured VL. 3 Furthermore, that IL10 plays an important role in the development of PKDL, 4 consistent with studies in mice showing a role of IL10 in the persistence of L. major in the skin after healing.
14 Our results suggest that failure of PKDL patients to respond adequately to IFNg at this post-treatment phase of infection may result in bias towards the down regulatory role played by IL10, leading to the recrudescence of parasites in remote sites in the skin.
Overall, our study has demonstrated important differences in genetic susceptibility to VL and PKDL that may shed further light on the immunoregulatory pathways that are important in determining these different manifestations of disease in the Sudanese population.
Study population and methods

Ascertainment and sampling of families
The study was carried out on the Nilosaharan-speaking Masalit population who migrated from western Sudan in the early-mid 1980s to occupy villages along the Rahad River in the heart of the endemic area in eastern Sudan. Epidemiological and demographic details relating to the study site are described in detail elsewhere. 1 Longitudinal data from the study area collected between 1991 and 1993 showed that 56% of treated VL patients that were followed up for 6 months developed PKDL. 1 This high rate of PKDL has been confirmed in more recent studies from the same study site, and from other study sites within eastern Sudan (reviewed in Zijlstra and ElHassa 15 ). Furthermore, PKDL in Sudan usually occurs within 0-6 months after treatment for VL, with a smaller percentage (8% 16 ) occurring between 7 and 13 months after treatment. This is in stark contrast to India where PKDL occurs 2-7 years after VL. 15 Multicase families with VL with/without PKDL were ascertained from epidemiological and medical records of the Institute of Endemic Diseases. Diagnosis was made on the basis of clinical, parasitological and serological criteria as described. 1, 15 All VL cases were monitored for a minimum of 2 years after treatment. Hence, cases classified as VL alone were unlikely to have proceeded to the PKDL clinical phenotype. Clinical subgroups are referred to as VL alone, VL with PKDL ( ¼ PKDL), or 'VL alone plus VL with PKDL,' which we refer to as VL per se, that is, looking for a gene controlling underlying susceptibility 19 were also typed. For the VNTR, PCR products were run on 1% agarose gels. Microsatellites were typed using FAM-, TAMRA-or HEX-labeled forward primers with PCR products analyzed by electrophoresis on 6% polacrylamide gels using an automated sequencer (model ABI377, Applied Biosystems) and the computer software genescan and genotyper (Applied Biosystems). IL4RP1 had 17 (14 45%) alleles, IL9 10 (745%) alleles and IFNGR1 11 (945%) alleles, respectively, in this population. 
Linkage analyses
Nonparametric linkage analysis was performed in Allegro 20 using the S pairs scoring function with 0.5 weighting to take account of differences in family size. Allegro reports allele sharing LOD scores and maximum Z-scores for the likelihood ratio (Z lr ). One-sided P-values associated with LOD and Zlr scores are used throughout. For multipoint analysis, genetic distances between markers were entered in cM calculated on the basis of the physical map distance (1 Mb ¼ 1 cM). The fraction of the total inheritance information extracted by the available marker data is indicated by the 'information content'. Simulations performed in Allegro using a standard set of six microsatellite markers (7-10 alleles; 0.73 heterozygosity) demonstrated that the 59 families had 99% power to detect linkage up to a critical value equivalent to an allele sharing LOD score of 3.00 (P ¼ 0.0001) for PKDL and 100% power to detect LOD ¼ 3.95 (P ¼ 0.00001) for the combined phenotype of VL per se.
Allelic association testing
Family-based allelic association tests were performed using the TDT 21 correcting for clustering at the pedigree level and nonindependence between sibs using a robust sandwich estimator for the variance. Allelic and genotype associations, and relative risk estimates, were obtained by creating a 'case-pseudo-control' study where the 'cases' comprise the genotypes of the affected offspring, and the 'controls' are the one to three other genotypes (depending on whether phase is known or inferred) which the affected offspring might have received from the parents. 6 The relative risks were estimated using conditional logistic regression analysis, again employing robust variance estimates to control for pedigree clustering and a Wald w 2 test to indicate overall significance for allelic or genotype associations. A stepwise logistic-regression procedure 6 was used to evaluate the relative importance of variants at the different sites within IL4. Likelihood ratio tests or Wald w 2 tests (robust test) were used to compare models in which the main effects for both loci are modeled with one in which the main effects at the primary locus only are included. TDT tests allowed for grouping of alleles with expected transmission frequencies of o5%. Conditional logistic regression analyses allowed for grouping of alleles/genotypes with frequencies of o5%. All statistical packages employed were developed by David Clayton at the Cambridge Institute for Medical Research and are available at http://www-gene.cimr.cam.ac.uk/ clayton/software/
